PRZOOM - /newswire/ -
London, United Kingdom, 2008/05/27 - Price erosion, budgetary constraints, reimbursement issues and the cannibalisation of mechanical valves by tissue valves are all challenges facing the European heart valve repairs markets.
However, the growth of tissue valves, paralleled by the rising popularity of minimally invasive techniques, will continue to drive the growth of this market.
New analysis from Frost & Sullivan (medicaldevices.frost.com), Heart Valve Repairs Markets in Europe, finds that the markets earned revenues of $263.7 million in 2007 and estimates this to reach $398.3 in 2014.
"Continuous inroads made by tissue valves and the development of minimally invasive techniques such as percutaneous heart valve therapies (PHVT) are driving the expansion of the heart valve repairs markets," notes Frost & Sullivan Research Analyst Sowmya Rajagopalan. "The risk to the patient is drastically minimised by these techniques, reinforcing the increased level of confidence in them."
Unlike mechanical valves, tissue valves have exhibited low risk of anti-coagulation. Improved technology and nearly two decades of research studies have helped expand the use of tissue valves, with an increasing number of patients opting to use them. PHVT-based measures for heart valve repairs will also boost this market because of the ease of implantation, resulting in the minimisation of post-operative risks and complications.
However, market prospects will be hampered by the progressive decline in prices. Such price erosion is being caused by cost-cutting measures to accommodate deficits in healthcare budgets. The market will also slow down due to declining growth in the mechanical valves market.
"Market participants are trying to optimise prices because of competition," says Rajagopalan. "At the same time, government budgetary constraints are placing the onus of limiting prices on manufacturers."
To sustain market growth, industry participants should develop new technologies that reduce the risks for patients. In addition to these clinical benefits, such new technologies should be developed with cost optimisation in mind.
If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the Heart Valve Repairs Markets in Europe, then send an email to Patrick Cairns, Corporate Communications, at pcairns_pr[.]frost.com, with your full name, company name, title, telephone number, company email address, company website, city, state and country. Upon receipt of the above information, an overview will be sent to you by email.
Heart Valve Repairs Markets in Europe is part of the Medical Devices Growth Partnership Services Programme, which also includes research in the following markets: European External Defibrillators Market; European Custom Procedure Trays Market; and Reconstructive Surgeries Market in Europe. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.
Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team Membership™ empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents.
Heart Valve Repairs Markets in Europe - BA0A